Chiron (NASDAQ:CHIR)
Historical Stock Chart
From Jun 2019 to Jun 2024
![Click Here for more Chiron Charts. Click Here for more Chiron Charts.](/p.php?pid=staticchart&s=N%5ECHIR&p=8&t=15)
First graph, first sentence of release should read:
Chiron Corporation (NASDAQ:CHIR) today announced that it will convene
a special meeting of stockholders on Wednesday, April 12, 2006, to
vote to approve its proposed merger with Novartis AG (sted Tuesday,
April 18, 2006).
The corrected release reads:
CHIRON SCHEDULES SPECIAL MEETING OF STOCKHOLDERS TO APPROVE MERGER
WITH NOVARTIS
Chiron Corporation (NASDAQ:CHIR) today announced that it will
convene a special meeting of stockholders on Wednesday, April 12,
2006, to vote to approve its proposed merger with Novartis AG. The
meeting will be held at 8:30 a.m. PDT at Chiron's headquarters at 1450
53rd Street, Emeryville, California 94608. Stockholders at the close
of business on the record date of March 3, 2006, will be eligible to
vote at the special meeting. Chiron anticipates filing its definitive
proxy statement with the Securities and Exchange Commission on or
about Friday, March 3, 2006.
About Chiron
Chiron delivers innovative and valuable products to protect human
health by advancing pioneering science across the landscape of
biotechnology. The company works to deliver on the limitless promise
of science and make a positive difference in people's lives. For more
information about Chiron, please visit www.chiron.com.
Forward-Looking Statements
This news release contains forward-looking statements, including
statements regarding the date of the special meeting of stockholders
and the filing of the definitive proxy statement with the SEC. These
statements are subject to a number of risks and uncertainties and are
subject to change. There can be no assurance that the special meeting
will be held as described or that the proxy statement will be filed on
the date indicated.
Chiron does not undertake an obligation to update the
forward-looking information the company is giving today.
Participants in Solicitation
Chiron Corporation and Novartis AG and Novartis Corporation and
their respective directors and executive officers may be deemed to be
participants in the solicitation of proxies from Chiron stockholders
in connection with the merger. Information about the directors and
executive officers of Chiron and their ownership of Chiron's stock is
set forth in the proxy statement for Chiron's 2005 Annual Meeting of
Stockholders. Investors can obtain more information when the
definitive proxy statement for the proposed merger becomes available.
Investors should read the definitive proxy statement and Schedule
13E-3 carefully before making any voting decision.